Lioyd
Glynn David Lioyd, Southampton GB
Patent application number | Description | Published |
---|---|---|
20100232961 | FIBRE OPTIC SENSORS - A wind turbine blade ( | 09-16-2010 |
Gregory Joseph Lioyd, Charlotte, NC US
Patent application number | Description | Published |
---|---|---|
20120239465 | ALLOCATING REWARDS FROM A REWARDS ACCOUNT - A method for allocating rewards across a plurality of rewards programs, each associated with one or more accounts owned by a customer, the method includes receiving customer input indicating that one or more rewards associated with a first rewards program should be associated with a second rewards program, determining a conversion factor configured for assisting conversion of the one or more rewards from the first rewards program to the second rewards program, applying, using a processing device, the conversion factor to the one or more rewards, thereby resulting in one or more converted rewards; and associating the one or more converted rewards with the second rewards program. | 09-20-2012 |
20120239482 | CUSTOMER AWARENESS PLATFORM - A system and method for providing a customer-centric rewards interface configured to communicate to a customer information related to one or more rewards programs associated with one or more customer accounts includes authenticating an identity of the customer, receiving customer input requesting presentation of the rewards interface, and initiating presentation, using a processing device, to the customer of the rewards interface comprising information related to one or more rewards programs associated with the customer. | 09-20-2012 |
Kenneth Lioyd, New York, NY US
Patent application number | Description | Published |
---|---|---|
20110129483 | Membrane transporter NaPi2b (SCL34A1) epitope for antibody therapy, antibodies directed thereto, and target for cancer therapy - The present disclosure relates generally to the membrane transporter NaPi2b (SLC34A2) as a target for therapy, including immunotherapy, and particularly cancer therapy. The SLC34A2 epitope peptide encompassing amino acids 312-340 of SLC34A2 has been identified as an ovarian cancer epitope using the monoclonal antibody MX35. The invention also relates to the use of SLC34A2 and particularly SLC34A2 peptides in generating antibodies which have anti-tumor or anti-cancer activity or in stimulating an immunological response. The invention further relates to antibodies specifically directed against NaPi2b (SLC34A2) and the SLC34A2 peptide (s), including veneered, chimeric, single chain and humanized antibodies. Methods for generating an immune response and for treatment of tumors and cancer are also provided. Assays for screening and identifying compounds directed against SLC34A2, including the SLC34A2 epitope peptide, and additional antibodies are provided. | 06-02-2011 |
Thomas W. Lioyd, Eagan, MN US
Patent application number | Description | Published |
---|---|---|
20130085378 | COMBINED FIELD LOCATION AND MRI TRACKING - A method of calibrating field location tracking to magnetic resonance tracking is provided. The method of calibration field location tracking includes moving a medical device throughout a plurality of points within a patient volume; tracking the medical device with a field location tracking system and a magnetic resonance tracking system; calculating a plurality of magnetic resonance tracking locations; determining a plurality of field location parameters that correspond to the plurality of magnetic resonance tracking locations; and creating a transfer function that maps the field location parameters to the magnetic resonance tracking locations, wherein the transfer function registers a field location coordinate system to a magnetic resonance coordinate system. | 04-04-2013 |